Transplantation Proceedings

Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver
pp. 237-241(5)
Authors: Kobayashi N.; Miyazaki M.; Fukaya K.; Inoue Y.; Sakaguchi M.; Noguchi H.; Tanaka N.; Namba M.

Development of new techniques using genetic and tissue engineering for the treatment of severe heart failure
pp. 242-244(3)
Authors: Sawa Y.; Fukushima N.; Nishimura M.; Sakaguchi T.; Ohtake S.; Matsuda H.

Adenovirus-mediated gene transfer of IL-4 prolongs rat renal allograft survival and inhibits the p21^ras-activation pathway
pp. 245-246(2)
Authors: Kato H.; Ritter T.; Ke B.; Murakami M.; Kusano M.; Busuttil R.W.; Kupiec-Weglinski J.W.

Adenovirus-mediated allograft transduction of interleukin-10: role in the induction phase of liver allograft acceptance
pp. 247-248(2)
Authors: Shinozaki K.; Yahata H.; Hayamizu K.; Tashiro H.; Fan X.; Okimoto T.; Tanji H.; Sakaguchi T.; Ito H.; Asahara T.

Usefulness of flow-cytometric cell sorting for enrichment of hepatic stem and progenitor cells in the liver
pp. 249-251(3)
Authors: Taniguchi H.; Suzuki A.; Zheng Y.; Kondo R.; Takada Y.; Fukunaga K.; Seino K.; Yuzawa K.; Otsuka M.; Fukao K.; Nakauchi H.

Mechanisms of immunomodulation induced by blood transfusion: identification of humoral factors
pp. 255-256(2)
Authors: Uchida H.; Tanaka H.; Kitoh Y.; Yanagisawa K.; To H.; Tago K.; Mizuta K.; Fujimura A.; Tominaga S.; Hashizume K.; Kobayashi E.

Prolongation of mouse skin allograft survival by novel agonists selective for retinoic acid receptor-
pp. 257-258(2)
Authors: Seino K.; Yamauchi T.; Ishibashi A.; Tokuhara N.; Kobayashi S.; Fukunaga K.; Taniguchi H.; Takada Y.; Yuzawa K.; Otsuka M.; Todoroki T.; Fukao K.

Oral administration of alloantigen plus nondepleting Anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts
pp. 259-259(1)
Authors: Niimi M.; Ikeda Y.; Shirasugi N.; Shatari T.; Takami H.; Kodaira S.; Matsumoto K.; Hamano K.; Esato K.; Hara M.; Wood K.J.

Graft hyporeactivity induced by donor-derived dendritic cell progenitors
pp. 260-264(5)
Authors: Hirano A.; Fraser M.O.; Jordan M.L.; Takayama T.; Lu L.; Thomson A.W.

Clinical utility of monitoring sialyl lewis^x (CD15s) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation
pp. 265-268(4)
Authors: Ishida H.; Koyama I.; Sawada T.; Murakami T.; Utsumi K.; Sannomiya A.; Tsuji K.; Tojimbara T.; Nakajima I.; Tanabe K.; Fuchinoue S.; Yamaguchi Y.; Toma H.; Agishi T.

FTY720 blocks allograft rejection by homing of lymphocytes in vivo
pp. 269-269(1)
Authors: Yuzawa K.; Stephkowski S.M.; Wang M.; Kahan B.D.

Graft survival rates of kidneys harvested from non-heart-beating donors using in situ machine washout
pp. 273-274(2)
Authors: Sakamoto K.; Arita S.; Yoshida T.; Yamada H.; Kusume K.; Kenmochi T.; Hori S.; Gunji Y.; Suzuki T.; Asano T.; Ochiai T.; Kashiwabara H.; Yokoyama T.

Prediction of kidney nonfunction after transplantation with machine perfusion preservation
pp. 275-276(2)
Authors: Kozaki K.; Sakurai E.; Kubota K.; Iwamoto H.; Hama K.; Narumi Y.; Uchiyama M.; Kikuchi K.; Degawa H.; Matsuno N.; Kozaki M.; Nagao T.

Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation
pp. 277-278(2)
Authors: Takada Y.; Fukunaga K.; Gu M.; Ishiguro S.; Taniguchi H.; Seino K.; Yuzawa K.; Otsuka M.; Fukao K.

Lung transplantation from non-heart-beating donors
pp. 279-280(2)
Authors: Shimada K.; Kondo T.; Okada Y.; Matsumura Y.; Oyaizu T.; Handa M.; Ichinose T.; Sado T.; Fujimura S.

Studies of the multiorgan procurement system from non-heart-beating donors
pp. 281-284(4)
Authors: Fukushima N.; Shirakura R.; Ohtake S.; Sawa Y.; Nishimura M.; Kobayashi Y.; Saito S.; Matsuda H.

Suppression of antigen-antibody reaction in xenotransplantation
pp. 287-288(2)
Authors: Kobayashi T.; Yokoyama I.; Ogawa H.; Nagasaka T.; Liu D.; Kato T.; Tokoro T.; Namii Y.; Hayashi S.; Muramatsu T.; Kadomatsu K.; Muramatsu H.; Takagi H.; Morozumi K.; Oikawa T.; Usami T.; Katayama A.; Haba T.; Tominaga Y.; Uchida K.; Nakao A.

Xenogeneic and allogeneic skin grafting after retrovirus-mediated SLA Class II DR gene transfer in baboons
pp. 289-290(2)
Authors: Gojo S.; Shimizu A.; Ierino F.L.; Banerjee P.T.; Cooper D.K.C.; LeGuern C.; Sachs D.H.

Pig kidney target cell PK15 apoptosis was inhibited by the cytokine response modifier A gene via suppression of caspase activity
pp. 291-292(2)
Authors: Fujino M.; Li X.-K.; Funeshima N.; Kimura H.; Amano T.; Hashimoto M.; Okabe K.; Yaginuma H.; Mikoshiba K.; Shinomiya T.; Enosawa S.; Amemiya H.; Suzuki S.

Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells
pp. 293-294(2)
Authors: Morita H.; Sugiura K.; Nagahama T.; Sakakura Y.; Tu W.; Oda M.; Inoue T.; Inui H.; Taketani S.; Kamiyama Y.; Ikehara S.

T-Cell receptor V usage of xeno-MHC-restricted CD4⁺ T cells in concordant xenoantigen recognition
pp. 295-298(4)
Authors: Iida Y.; Hirose H.; Hirota T.; Kanetake K.; Umeda Y.; Nitta T.; Matsuno Y.; Yoshikawa S.; Takagi H.; Mori Y.; Iwata H.

Glomerular changes in a 1-year posttransplant protocol biopsy as a useful predictive indicator in ABO-Incompatible kidney transplantation
pp. 301-305(5)
Authors: Aikawa A.; Miyagi M.; Hasegawa A.; Ohara T.; Hadano T.; Nakano H.; Mori Y.; Iwamoto M.; Sakai K.; Mizuiri S.

Multilayering of peritubular capillary is a specific diagnostic criterion for immunologic chronic rejection: does a humoral factor contribute to the pathogenesis of peritubular capillary lesions in chronic rejection?
pp. 306-307(2)
Authors: Takeuchi O.; Oikawa T.; Koyama K.; Usami T.; Shimano Y.; Ito A.; Katoh M.; Otsuka Y.; Takeda A.; Haba T.; Uchida K.; Morozumi K.

Histopathologic findings of renal allografts surviving more than 10 years after transplantation
pp. 308-310(3)
Authors: Yamaguchi Y.; Tanabe K.; Shimizu T.; Matsugami K.; Fuchinoue S.; Toma H.; Agishi T.

Ascorbic acid 2-glucoside prevents sinusoidal endothelial cell apoptosis in supercooled preserved grafts in rat liver transplantation
pp. 313-317(5)
Authors: Matsukawa H.; Yagi T.; Matsuda H.; Kawahara H.; Yamamoto I.; Matsuoka J.; Tanaka N.

Protective effect of OPC-6535, a superoxide anion production inhibitor, on liver grafts subjected to warm ischemia during porcine liver transplantation
pp. 318-321(4)
Authors: Ejiri S.; Eguchi Y.; Kishida A.; Kurumi Y.; Tani T.; Kodama M.

Influence of donor condition on postoperative graft survival and function in human liver transplantation
pp. 322-326(5)
Authors: Totsuka E.; Fung J.J.; Ishii T.; Urakami A.; Moras N.P.; Hakamada K.; Narumi S.; Watanabe N.; Nara M.; Hashimoto N.; Takiguchi M.; Nozaki T.; Umehara Y.; Sasaki M.

Liver transplants from brain-dead donors: microcirculation and histomorphology
pp. 327-327(1)
Authors: Okamoto S.; Yamamoto Y.; Yamaoka Y.; Messmer K.

Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease
pp. 331-333(3)
Authors: Kato T.; Tokoro T.; Namii Y.; Kobayashi T.; Hayashi S.; Yokoyama I.; Morimoto S.; Chan M.; Giannetti N.; Hunt S.A.

Influence of alveolar gas during pulmonary preservation on reperfusion injury
pp. 334-335(2)
Authors: Fukuse T.; Hirata T.; Hitomi S.; Wada H.

Clinical controversy concerning the use of cryopreserved allografts in cardiovascular surgery
pp. 336-338(3)
Authors: Moriyama S.; Utoh J.; Sun L.-B.; Okamoto K.; Kunitomo R.; Hirose K.; Kitamura N.

Development of a fully automated islet digestion system
pp. 341-343(3)
Authors: Kenmochi T.; Asano T.; Jingu K.; Iwashita C.; Miyauchi H.; Takahashi S.; Saito T.; Ochiai T.

The use of thymoglobuline induction in renal transplantation: a pharmacovigilance study
pp. 351-352(2)
Authors: Hurault de Ligny B.; Lebranchu Y.

Antibodies to vascular endothelial cells in chronic rejection of renal allografts
pp. 353-354(2)
Authors: Ball B.; Mousson C.; Ratignier C.; Guignier F.; Glotz D.; Rifle G.

Endothelial cells provide costimulatory signals to trigger both allogeneic adult and cord blood (NAIVE) CD4+ T-Cell proliferation
pp. 355-356(2)
Authors: Camara N.O.S.; Cappellesso S.; Watier H.; Lebranchu Y.

Cytomegalovirus infection in kidney allograft recipients is followed by a prolonged expansion of T lymphocytes
pp. 357-359(3)
Authors: Merville P.; Dechanet J.; Berge F.; Bone-Mane G.; Taupin J.-L.; Michel P.; Joly P.; Bonneville M.; Potaux L.; Moreau J.-F.

Antimonocyte sensitization after kidney transplantation
pp. 360-360(1)
Authors: Suberbielle-Boissel C.; Meshaka G.; Legendre C.; Kreis H.; Charron D.; Raffoux C.

Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase
pp. 361-363(3)
Authors: Dervieux T.; Medard Y.; Baudouin V.; Maisin A.; Zhang D.; Loirat C.; Jacqz-Aigrain E.

Modulation of the proliferation and gene expression of vascular smooth muscle cells induced by lymphocyte culture supernatants¹
pp. 364-366(3)
Authors: Artigas S.; Blaes N.; Garcia V.; Caspar-Bauguil S.; Benoist H.; Thomsen M.

Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies
pp. 367-367(1)
Authors: Charpentier B.; Hiesse C.; Marchand S.; Boubenider S.; Ammor M.; Kechrid C.; Benoit G.; Durrbach A.

Approaches toward T cell-independent and -dependent xenograft tolerance
pp. 371-373(3)
Authors: Xia G.L.; Ji P.; Rutgeerts O.; Waer M.

Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues
pp. 377-378(2)
Authors: Legendre C.; Thervet E.

Impact of donor-related vascular alterations in implantation biopsies on morphologic and functional outcome of cadaveric renal allografts
pp. 379-380(2)
Authors: Bosmans J.L.; Woestenburg A.T.; Helbert M.J.; Ysebaert D.K.; Van Marck E.; De Broe M.E.; Verpooten G.A.

Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome
pp. 381-383(3)
Authors: Mariat C.; Alamartine E.; De Filippis J.P.; Deprele C.; Le Petit J.C.; Goure D.; Berthoux F.

Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
pp. 384-385(2)
Authors: Antoine C.; Landau A.; Menoyo V.; Duong J.P.; Duboust A.; Glotz D.

Cytokine expression in peripheral CD57⁺ T cells from tolerant renal allograft recipients
pp. 386-387(2)
Authors: Hebib C.; Rouleau M.; Hirsch F.; Durrbach A.; Legendre C.; Senik A.; Charpentier B.

Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients
pp. 388-390(3)
Authors: Aigrain E.J.; Shaghaghi E.K.; Baudouin V.; Popon M.; Loirat C.

Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results
pp. 391-392(2)
Authors: Pattou F.; Vantyghem M.C.; Noel C.; Kerr-Conte J.; Gmyr V.; Martinache I.; Vandewalle B.; N'Guyen H.; Lecomte-Houcke M.; Lefebvre J.; Proye C.

European multicenter survey on noncompliance after solid organ transplantation
pp. 393-395(3)
Authors: Pruna A.; Fornairon S.

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids
pp. 396-397(2)
Authors: Lebranchu Y.; Aubert P.; Bayle F.; Bedrossian J.; Berthoux F.; Bourbigot B.; Buchler M.; Chalopin J.M.; Deteix P.; Glotz D.; Huraut De Ligny B.; Kessler M.; Lang P.; Lefrancois N.; Le Pogamp P.; Moulin B.; Mourad G.; Olmer M.; Sraer J.D.; Touchard G.; Toupance O.; Wolf P.; Puget S.

Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients
pp. 398-398(1)
Authors: Vela C.G.; Cristol J.P.; Descomps B.; Mourad G.

Successful endoluminal thromboaspiration of renal graft venous thrombosis
pp. 399-400(2)
Authors: Rerolle J.P.; Antoine C.; Raynaud A.; Beyssen B.; Julia P.; Duboust A.; Glotz D.

Improvement of parathyroid function after kidney transplantation: effect on parathyroid functional mass
pp. 401-403(3)
Authors: Bonarek H.; Merville P.; Bonarek M.; Moreau K.; Morel D.; Aparicio M.; Potaux L.

Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation
pp. 404-406(3)
Authors: Mourad M.; Chaib-Eddour D.; Malaise J.; Konig J.; Squifflet J.P.; Wallemacq P.E.

Emergence of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient
pp. 407-407(1)
Authors: Bienvenu B.; Thervet E.; Bedrossian J.; Scieux C.; Mazeron M.C.; Thouvenot D.; Legendre C.

Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion
pp. 408-410(3)
Authors: Besse T.; Malaise J.; De Meyer M.; Mourad M.; Squifflet J.P.

Bone mineral density in posttransplantation patients: effects of physical activity
pp. 411-414(4)
Authors: Cordier P.; Decruynaere C.; Devogelaer J.P.

Muscle energetics in immunosuppressed patients
pp. 415-417(3)
Authors: Francaux M.; Versieux L.; Van Hecke P.; Cordier P.

Anti-HLA sensitization against graft specificities after kidney transplantation: use of PRA-stat ELISA
pp. 418-418(1)
Authors: Suberbielle-Boissel C.; Legendre C.; Meunier D.; Kreis H.; Charron D.; Raffoux C.

T lymphocytes expressing NK antigens: kinetics after renal transplantation
pp. 419-420(2)
Authors: Alamartine E.; Videcoq C.; Saby P.; Sabido O.; Berthoux F.

Kidney-pancreas transplantation: our experience with systemic and portal drainage of pancreatic graft
pp. 421-422(2)
Authors: Martin X.; Dawahra M.; Lefrancois N.; Da Silva M.; Petruzzo P.; Pibiri L.; Feitosa L.C.; Dubernard J.M.

Histologic evolution of kidney graft after combined pancreas-kidney transplantation
pp. 423-424(2)
Authors: Rerolle J.P.; Thervet E.; Desgrandchamps F.; Nochy D.; Janin A.; Fornairon S.; Passa P.; Bedrossian J.; Legendre C.

Early renal function deterioration is the only predictive factor of graft failure after 1 year
pp. 425-426(2)
Authors: Thervet E.; Charpentier B.; Durand D.; Glotz D.; Lebranchu Y.; Lefrancois N.; Wolf P.

Antioxidant supplementation and chronic renal transplant dysfunction
pp. 427-428(2)
Authors: Vela C.; Cristol J.P.; Ribstein J.; Mimran A.; Descomps B.; Mourad G.

A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results
pp. 429-431(3)
Authors: Baldi A.; Malaise J.; Mourad M.; Squifflet J.P.

Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure
pp. 432-433(2)
Authors: Hammer F.D.; Malaise J.; Goffette P.P.; Mathurin P.

Cost analysis of kidney transplantation with cyclosporin A
pp. 434-435(2)
Authors: Cogny-Van Weydevelt F.; Dandavino R.; Langlois S.; Boucher A.

Pediatric renal transplantation: a single centre experience
pp. 436-436(1)
Authors: Van Damme-Lombaerts R.; Herman J.; Coosemans W.; Pirenne J.

Early posttransplant calcemia as a predictive indicator for parathyroidectomy in kidney allograft recipients with tertiary hyperparathyroidism
pp. 437-440(4)
Authors: Mourad M.; Malaise J.; Chautems R.C.; Hanique G.; Squifflet J.P.

Inferior epigastric artery for revascularization of lower polar arteries in renal transplantation
pp. 441-442(2)
Authors: Chautems R.C.; Mourad M.; Malaise J.; Squifflet J.-P.

Clinical correlation of acute rejection according to Banff classification in renal transplantation
pp. 443-444(2)
Authors: Lorriaux C.; Pouteil Noble C.; Dijoud F.; Cahen R.; Touraine J.L.; MacGregor B.

Nosocomial transmission of Pneumocystis carinii in renal transplantation
pp. 445-445(1)
Authors: Touzet S.; Pariset C.; Rabodonirina M.; Pouteil-Noble C.

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction
pp. 446-448(3)
Authors: Cantarovich M.; Quantz M.; Elstein E.; Ergina P.; Magnan C.; de Varennes B.

Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine
pp. 449-452(4)
Authors: Semhoun-Ducloux S.; Ducloux D.; Bresson-Hadni S.; Becker M.-C.; Vanlemmens C.; Mantion G.; Chalopin J.-M.; Miguet J.-P.

Review of living related versus cadaveric donors in pediatric liver transplantation: the Lyon experience
pp. 453-453(1)
Authors: Eid B.; Villard F.; Stamm D.; Mamoux V.; Bouvier R.; Canterino I.; Boillot O.; Lachaux A.

Hepatitis and solid organ transplantation
pp. 454-457(4)
Authors: Pol S.; Samuel D.; Cadranel J.-F.; Legendre C.; Bismuth H.; Brechot C.; Kreis H.

Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function
pp. 461-462(2)
Authors: Dureau G.; Obadia J.F.; Chuzel M.; Boissonnat P.

Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation
pp. 463-465(3)
Authors: Redonnet M.; Tron C.; Koning R.; Bouchart F.; Cribier A.; Soyer R.; Bessou J.P.

Nucleotide metabolism and ADPase activity in cardiac and renal transplantation
pp. 466-467(2)
Authors: Caillard S.; Charpentier A.; Ravannat C.; Cassel D.; Wiesel M.L.; Moulin B.; Cazenave J.P.; Gachet C.

Is partially reversible pulmonary hypertension a contraindication for heart transplantation?
pp. 468-469(2)
Authors: Baldovinos A.; Kalangos A.; Sierra J.; Licker M.-J.; Faidutti B.

Video-assisted live donor nephrectomy: a comparison with open surgery
pp. 473-474(2)
Authors: Malaise J.; Mourad M.; Squifflet J.-P.

Ischemia-reperfusion injury of rabbit kidney: comparative effects of desferrioxamine and N-Acetylcysteine as antioxidants
pp. 475-476(2)
Authors: Pincemail J.; Defraigne J.O.; Detry O.; Franssen C.; Meurisse M.; Limet R.

Limitation of ischemic damage to the renal medulla by trimetazidine added to Euro-Collins solution: evaluation in an autotransplant model
pp. 477-478(2)
Authors: Richer J.P.; Baumert H.; Gibelin H.; Faure J.P.; Hebrard W.; Amor I.B.; Carretier M.; Eugene M.; Tillement J.P.; Hauet T.

Mitochondrial and energetic dysfunctions of the liver during normothermic reperfusion: protective effect of cyclosporine and role of the mitochondrial permeability transition pore
pp. 479-480(2)
Authors: Leducq N.; Delmas-Beauvieux M.-C.; Bourdel-Marchasson I.; Dufour S.; Gallis J.-L.; Canioni P.; Diolez P.

Protective effect of an Anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation
pp. 481-481(1)
Authors: Martin X.; Da Silva M.; Virieux S.R.; Hadj Aissa A.; Buffet R.; Tiollier J.; Dubernard J.M.

Ischemia-reperfusion injury is associated with inflammatory cell infiltration: evaluation in a pig kidney autotransplant model
pp. 482-483(2)
Authors: Richer J.P.; Gibelin H.; Planet M.; Bardou A.; Ben Amor I.; Germonville T.; Caritez J.C.; Carretier M.; Eugene M.; Hauet T.

Antioxidant status after cold ischemia of rabbit lung
pp. 484-485(2)
Authors: Pincemail J.; Kolh P.; Detry O.; Lambermont B.; Meurisse M.; Limet R.; Defraigne J.O.

Laparoscopic living donor nephrectomy: University of Liege experience
pp. 486-487(2)
Authors: Detry O.; Hamoir E.; Defechereux T.; Bonnet P.; Honore P.; Meurisse M.

Laparoscopy-assisted living donor nephrectomy in combination with minilaparotomy
pp. 488-490(3)
Authors: Mourad M.; Malaise J.; Squifflet J.P.

Fatal methanol poisoning and organ donation: experience with seven cases in a single center
pp. 491-492(2)
Authors: Hantson P.; Vanormelingen P.; Lecomte C.; Dumont V.; Squifflet J.P.; Otte J.B.; Mahieu P.

Experimental study of a cooling jacket in renal transplantation
pp. 493-495(3)
Authors: Planet M.; Desgrandchamps F.; Hauet T.; Gourmel B.; Goujon B.; Carretier M.; Teillac P.; Grise P.; Le Duc A.

Trimetazidine added to University of Wisconsin during 48-hour cold preservation improves renal energetic status during reperfusion
pp. 496-497(2)
Authors: Hauet T.; Bauza G.; Richer J.P.; Hebrard W.; Carretier M.; Eugene M.; Tillement J.P.

Early evaluation of renal medulla injury by ¹H nuclear magnetic resonance spectroscopy after preservation and transplantation
pp. 498-499(2)
Authors: Baumert H.; Richer J.P.; Gibelin H.; Ben Amor I.; Caritez J.C.; Germonville T.; Carretier M.; Eugene M.; Hauet T.

Standardization of a non-heart-beating model in the rat for studying the mechanisms of renal cell death associated with cardiac arrest and preservation of the kidney
pp. 500-502(3)
Authors: Bellemare S.; Boucher A.; Dandavino R.; Marion A.; Dube P.; Pichette V.; Hebert M.-J.

Errata
pp. 503-504(2)